SK50372006A3 - Process for preparing 7-hydroxy-3,4-dihydrocarbostyril - Google Patents
Process for preparing 7-hydroxy-3,4-dihydrocarbostyril Download PDFInfo
- Publication number
- SK50372006A3 SK50372006A3 SK5037-2006A SK50372006A SK50372006A3 SK 50372006 A3 SK50372006 A3 SK 50372006A3 SK 50372006 A SK50372006 A SK 50372006A SK 50372006 A3 SK50372006 A3 SK 50372006A3
- Authority
- SK
- Slovakia
- Prior art keywords
- dihydrocarbostyril
- hydroxy
- hydrogenation
- impurity
- carried out
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Abstract
Description
Oblasť technikyTechnical field
Vynález sa týka spôsobu prípravy vysoko čistého 7-hydroxy-3,4-dihydrokarbostyrilu. Táto zlúčenina sa okrem iného používa ako medziprodukt výroby 7-{4-[4-(2,3-dichlorofenyl)-1 -piperazinyl]butoxy}-3,4-dihydrokarbostyrilu, respektíve 7-{4-[4-(2,3-dichlorofenyl)-l-piperazinyl]butoxy}-l,2,3,4-tetrahydrochinolín-2-ónu známeho pod názvom aripiprazol. Aripiprazol patrí do novej generácie antipsychotík, lebo pôsobí súčasne ako postsynaptický dopamín D2 antagonista a presynaptický dopamín D2 autoreceptorový parciálny agonista.The invention relates to a process for the preparation of highly pure 7-hydroxy-3,4-dihydrocarbostyril. This compound is used, inter alia, as an intermediate for the production of 7- {4- [4- (2,3-dichlorophenyl) -1-piperazinyl] butoxy} -3,4-dihydrocarbostyril and 7- {4- [4- (2, 3-dichlorophenyl) -1-piperazinyl] butoxy} -1,2,3,4-tetrahydroquinolin-2-one known as aripiprazole. Aripiprazole belongs to a new generation of antipsychotics, as it acts simultaneously as a postsynaptic dopamine D2 antagonist and a presynaptic dopamine D2 autoreceptor partial agonist.
Doterajší stav technikyBACKGROUND OF THE INVENTION
Aripiprazol III sa pripravuje podľa postupu EP 0 367 141, ekvivalent US 5 006 528, viď. nasledujúca schéma 1.Aripiprazole III is prepared according to the procedure of EP 0 367 141, equivalent to US 5 006 528, cf. the following scheme 1.
SCHÉMA 1SCHEME 1
Východisková stavebná jednotka 7-(4-halogénbutoxy)-3,4-dihydro-l/7-chinolín-2-ón I sa pripravuje podľa nasledujúcej schémy 2. (EP 0367141, J. Med. Chem. 1998 (41) 658 - 667, Chem. Pharm. Bull. 1988 (36) 4377 - 4388) *HOThe starting unit 7- (4-halobutoxy) -3,4-dihydro-1 H -quinolin-2-one I is prepared according to the following scheme 2. (EP 0367141, J. Med. Chem. 1998 (41) 658 - 667, Chem Pharm Bull 1988 (36) 4377-4388) HO
X = Br,Cl Y = Br,ClX = Br, Cl Y = Br, Cl
SCHÉMA 2SCHEME 2
X '0 * · · • » • · · ·»· ··« « · ·»» · ···«X '0 * · • • »'« '' '' '
-> · ·· ·····«· ·· « · · · · ···« '*'< ·«· · · · ·-> · · · · · «· · '' '' '' '' '' ''
Bežným spôsobom syntézy 7-hydroxy-3,4-dihydrokarbostyrilu IV je postup podľaA common method of synthesizing 7-hydroxy-3,4-dihydrocarbostyril IV is by the following procedure
Chem. Ber. 1927 (60) 858 - 864 (Schéma 3). Podľa tohto postupuje najprv v prvom kroku pripravený 3-chlór-3'-hydroxypropioanilid VI reakciou 3-aminofenolu VII s 3-chlórpropionylchloridom VIII v roztoku acetónu a v druhom kroku reaguje 3-chlór-3'-hydroxypropioanilid s chloridom hlinitým, sodným a draselným za vzniku 7-hydroxy-3,4-dihydrokarbostyrilu IV.Chem. Ber. 1927 (60) 858-864 (Scheme 3). Accordingly, in the first step the 3-chloro-3'-hydroxypropioanilide VI prepared by reacting 3-aminophenol VII with 3-chloropropionyl chloride VIII in acetone solution and in the second step reacting 3-chloro-3'-hydroxypropioanilide with aluminum, sodium and potassium chloride formation of 7-hydroxy-3,4-dihydrocarbostyril IV.
HO'HO '
SCHÉMA 3SCHEME 3
Ďalší postup prípravy 7-hydroxy-3,4-dihydrokarbostyrilu IV bol opísaný v roku 1969 v časopise J. Chem. Soc. Využíva Schmidtovu reakciu cyklického ketónu IX s azidom sodným v prostredí 93 % kyseliny sírovej (Schéma 4). Vzhľadom na vznik nežiaduceho izoméru X, ktorý znižuje výťažok požadovaného 7-hydroxy-3,4-dihydrokarbostyrilu IV a komplikuje jeho izoláciu v požadovanej kvalite, však táto reakcia nie je vhodná. Reakcia je ďalej problematická z hľadiska technologizácie. Výroba je zložitá vzhľadom na ťažkosti zaistenia bezpečnosti práce s azidom sodným a koncentrovanou kyselinou sírovou. V neposlednom rade je táto príprava nevhodná kvôli vzniku veľkého množstva ťažko likvidovateľných odpadov.A further procedure for the preparation of 7-hydroxy-3,4-dihydrocarbostyril IV was described in 1969 in J. Chem. Soc. It utilizes the Schmidt reaction of cyclic ketone IX with sodium azide in 93% sulfuric acid (Scheme 4). However, due to the formation of the undesired isomer X, which reduces the yield of the desired 7-hydroxy-3,4-dihydrocarbostyril IV and complicates its isolation at the desired quality, this reaction is not appropriate. Furthermore, the reaction is problematic in terms of technology. Production is complicated due to the difficulty of ensuring the safety of working with sodium azide and concentrated sulfuric acid. Last but not least, this preparation is unsuitable because of the large amount of waste that can be disposed of.
SCHÉMA 4SCHEME 4
Experimentálne bolo zistené, že postupom podľa Chem. Ber. 1927 (60) 858 - 864 (Príklady 1 a 2) vzniká silne znečistený produkt 7-hydroxy-3,4-dihydrokarbostyril IV. Podľa ·> οExperimentally it was found that following the procedure of Chem. Ber. 1927 (60) 858-864 (Examples 1 and 2), a highly contaminated 7-hydroxy-3,4-dihydrocarbostyril IV product is formed. According to ·> ο
HPLC analýzy produkt IV obsahoval 2 % nečistoty, ktorá bola identifikovaná pomocou LC-MS ako látka s molekulovou hmotnosťou nižšou o 2 jednotky než produkt, to znamená, že nečistotou je 7-hydroxykarbostyril 1.HPLC analysis product IV contained 2% impurity, which was identified by LC-MS as a molecular weight lower than 2 units than the product, i.e. the impurity is 7-hydroxycarbostyril 1.
HO N XOHO N X O
HH
To bolo tiež potvrdené z NMR spektier vzorky, ktorá obsahovala väčšie množstvo tejto nečistoty (6 %). Obsah nečistoty 1 kolísal obvykle od 2 do 10 % pri jednotlivých pokusoch.This was also confirmed from the NMR spectra of a sample that contained a larger amount of this impurity (6%). The impurity 1 content usually varied from 2 to 10% in individual experiments.
Ďalej bolo preukázané, že ak je použitý takto znečistený 7-hydroxy-3,4-dihydrokarbostyril IV na prípravu aripiprazolu, indukuje nečistota 1 v nasledujúcich syntéznych krokoch vznik ďalších nečistôt, ako sú napríklad nečistoty 2, 3, 4. Výsledný aripiprazol je tak získaný v nízkom výťažku aj čistote a nie je teda vhodný na použitie vo farmaceutickom priemysle.Furthermore, it has been shown that when so contaminated 7-hydroxy-3,4-dihydrocarbostyril IV is used for the preparation of aripiprazole, impurity 1 induces further impurities such as impurities 2, 3, 4 in subsequent synthesis steps. The resulting aripiprazole is thus obtained in low yield and purity and is therefore not suitable for use in the pharmaceutical industry.
X=Br, ClX = Br, Cl
Na odstránenie alebo výrazné zníženie obsahu nečistoty 1 v surovom 7-hydroxy-3,4-dihydrokarbostyrile boli uskutočňované iba neúspešné pokusy spočívajúce v kryštalizácii z nasledujúcich rozpúšťadiel: voda, etylacetát, 80 % vodný etanol, 1-butanol, izobutylmetylketón, metanol, 2-propanol, etanol, dichlórmetán a ich zmesi. Ďalej boli skúšané, tiež neúspešne, derivatizácie 3,4- dvojitej väzby 7-hydroxykarbostyrilu jej hydroxyláciou, prípadne bromáciou alebo hydrogenáciou za normálneho tlaku.To remove or significantly reduce the impurity 1 content in the crude 7-hydroxy-3,4-dihydrocarbostyril, only unsuccessful crystallization experiments were performed consisting of the following solvents: water, ethyl acetate, 80% aqueous ethanol, 1-butanol, isobutylmethylketone, methanol, 2- propanol, ethanol, dichloromethane and mixtures thereof. Furthermore, derivatization of the 3,4-double bond of 7-hydroxycarbostyril by its hydroxylation, optionally by bromination or hydrogenation under normal pressure, was also attempted, unsuccessfully.
Problém znečistenia 7-hydroxy-3,4-dihydrokarbostyrilu IV zlúčeninou 7-hydroxykarbostyril 1 rieši nový spôsob prípravy vysoko čistého 7-hydroxy-3,4-dihydrokarbostyrilu IV, ktorý je predmetom vynálezu.The problem of contamination of 7-hydroxy-3,4-dihydrocarbostyril IV with 7-hydroxycarbostyril 1 solves the novel process for the preparation of the highly pure 7-hydroxy-3,4-dihydrocarbostyril IV object of the invention.
Λ -Podstata vynálezu- Summary of the Invention
Podstatou vynálezu je spôsob prípravy 7-hydroxy-3,4-dihydrokarbostyrilu IV s čistotou vyššou než 98 %, ktorý je možné okrem iného použiť ako medziprodukt výroby 7-{4-[4-(2,3-dichlorofenyl)-l-piperazinyl]butoxy}-3,4-dihydrokarbostyrilu, respektíve 7-{4-[4-(2,3—dichlorofenyl)-l-piperazinyl]butoxy}-l,2,3,4-tetrahydrochinolín-2-ónu známeho pod názvom aripiprazol. Postup podľa vynálezu je založený na efektívnom čistení 7-hydroxy-3,4-dihydrokarbostyrilu IV, ktoré spočíva v selektívnej redukcii dvojitej väzby nečistoty 7-hydroxykarbostyrilu 1, ktorá je uskutočňovaná katalytickou hydrogenáciou, najmä hydrogenáciou plynným vodíkom za katalýzy Pd na aktívnom uhlí. Takto je získaný veľmi čistý 7-hydroxy-3,4-dihydrokarbostyril, ktorý môže byť použitý na prípravu farmaceutickej substancie aripiprazol.SUMMARY OF THE INVENTION The present invention provides a process for the preparation of 7-hydroxy-3,4-dihydrocarbostyril IV having a purity of greater than 98%, which can be used inter alia as an intermediate of production of 7- {4- [4- (2,3-dichlorophenyl) -1-piperazinyl ] butoxy} -3,4-dihydrocarbostyril and 7- {4- [4- (2,3-dichlorophenyl) -1-piperazinyl] butoxy} -1,2,3,4-tetrahydroquinolin-2-one, respectively known as aripiprazole. The process according to the invention is based on the effective purification of 7-hydroxy-3,4-dihydrocarbostyril IV, which consists in the selective reduction of the double bond of the impurity 7-hydroxycarbostyril 1 by catalytic hydrogenation, in particular hydrogenation by hydrogen gas under catalysis of Pd on activated carbon. Thus, very pure 7-hydroxy-3,4-dihydrocarbostyril is obtained, which can be used to prepare the pharmaceutical substance aripiprazole.
Po rade neúspešných pokusov o vyčistenie 7-hydroxy-3,4-dihydrokarbostyrilu pomocou kryštalizácie z rôznych rozpúšťadiel a derivatizácie 3,4-dvojitej väzby 7-hydroxykarbostyrilu jej hydroxyláciou, prípadne bromáciou alebo hydrogenáciou za normálneho tlaku sa ukázala jediným efektívnym riešením na prípravu čistého aripiprazolu selektívna redukcia dvojitej väzby.After a series of unsuccessful attempts to purify 7-hydroxy-3,4-dihydrocarbostyril by crystallization from various solvents and derivatizing the 3,4-double bond of 7-hydroxycarbostyril by its hydroxylation or bromination or hydrogenation under normal pressure, it has proven to be the only effective solution for preparing pure aripiprazole. selective reduction of the double bond.
V literatúre sú opísané len redukcia na karbostyrile, nie na 7-hydroxykarbostyrile. Z redukcií na karbostyrile sú opísané tieto spôsoby: elektrochemická redukcia na Ni katóde (Helv. Chim. Acta 32, 1949, 1278), redukcia sodíkom vmetanole, pri ktorej vzniká perhydrochinolín (Chem. Ber. 19, 1886, 3302), redukcia sodíkovým amalgámom v etanole (Chem. Ber. 20, 1887, 2012), redukcia horčíkom v metanole, ktorá však dáva len 30 % výťažok (J. Chem. Soc. Perkin Transl, 1981, 2912). Z hydrogenačných metód prevodu karbostyrilu na 3,4-dihydrokarbostyril je opísaná redukcia vodíkom s katalýzou oxidu platičitého (Heterocycles 28 (2), 1989, 1085). Žiadny z týchto skôr opísaných spôsobov však nevykazoval dostatočný účinok pri čistení 7-hydroxy-3,4-dihydrokarbostyrilu.Only reduction to carbostyril, not to 7-hydroxycarbostyril, is described in the literature. Among the reductions to carbostyril, the following methods are described: electrochemical reduction on Ni cathode (Helv. Chim. Acta 32, 1949, 1278), sodium reduction in methanol to produce perhydroquinoline (Chem. Ber. 19, 1886, 3302), sodium amalgam reduction in ethanol (Chem. Ber. 20, 1887, 2012), reduction with magnesium in methanol, but yielding only a 30% yield (J. Chem. Soc. Perkin Transl, 1981, 2912). Hydrogenation methods of converting carbostyril to 3,4-dihydrocarbostyril have described hydrogen reduction with platinum oxide catalysis (Heterocycles 28 (2), 1989, 1085). However, none of the above-described methods showed a sufficient effect in the purification of 7-hydroxy-3,4-dihydrocarbostyril.
Zďaleka najvýhodnejším spôsobom čistenia 7-hydroxy-3,4-dihydrokarbostyrilu sa prekvapivo ukázala selektívna hydrogenácia plynným vodíkom za katalýzy Pd na aktívnom uhlí (podľa Príkladu 3). Pri vhodne zvolených reakčných podmienkach táto metóda poskytla intermediát s čistotou 99,7 % a s obsahom nečistoty 1 0,04%. Vhodným prostredím na uskutočnenie hydrogenácie sa ukázali Ci až C4 alkoholy, najmä potom metanol. Účinným katalyzátorom reakcie bol Pd katalyzátor na aktívnom uhlí s obsahom paládia 1 - 10 % pri koncentrácii katalyzátora v reakčnej zmesi 1-10 hmôt. %, najmä potom pri koncentrácii 4 hmôt. % v reakčnej zmesi a s obsahom Pd 1,5 %. Plynný vodík je možné do reakčnej zmesi privádzať pod tlakom 0,1 - 10 MPa, počas 3-10 hod a pri teplote 40 - 100 °C, výhodne pri tlaku 3-4 MPa, počas 7 hod a pri teplote 70 - 80 °C.Surprisingly, by far the most preferred method of purification of 7-hydroxy-3,4-dihydrocarbostyril has been the selective hydrogenation of hydrogen gas with Pd on activated carbon (according to Example 3). Under suitably selected reaction conditions, this method gave an intermediate having a purity of 99.7% and an impurity content of 1.04%. C 1 -C 4 alcohols, especially methanol, have been found to be suitable for the hydrogenation. An effective catalyst for the reaction was a Pd catalyst on activated carbon with a palladium content of 1-10% at a catalyst concentration in the reaction mixture of 1-10 wt. %, in particular at a concentration of 4% by weight. % in the reaction mixture and having a Pd content of 1.5%. Hydrogen gas can be introduced into the reaction mixture under a pressure of 0.1-10 MPa, for 3-10 hours and at a temperature of 40-100 ° C, preferably at a pressure of 3-4 MPa, for 7 hours and at a temperature of 70-80 ° C. .
Príklady uskutočnenia vynálezuDETAILED DESCRIPTION OF THE INVENTION
Príklad 1Example 1
Príprava 3-chlór-3 '-hydroxypropioaniliduPreparation of 3-chloro-3'-hydroxypropioanilide
3-Aminofenol VII (0,4 mol) bol rozpustený v 40 ml sušeného acetónu a pod spätným chladičom za chladenia na vodnom kúpeli bol do roztoku prikvapkávaný roztok 3-chlórpropionylchloridu VIII (0,2 mol) v 40 ml sušeného acetónu. Suspenzia bola zahriata na 50 °C a po 1 hodine miešania bola reakčná zmes naliata do 300 ml IM kyseliny chlorovodíkovej. Bolo pridaných 150 ml vody a zmes bola miešaná pri laboratórnej teplote. Vylúčené kryštály boli odsaté a sušené pri 90 °C. Takto bolo získaných 30 g 3-chlór-3'-hydroxypropioanilidu VI (75 % teória) s teplotou topenia 134 - 135 °C.3-Aminophenol VII (0.4 mol) was dissolved in 40 ml of dried acetone and a solution of 3-chloropropionyl chloride VIII (0.2 mol) in 40 ml of dried acetone was added dropwise to the solution while cooling in a water bath. The suspension was heated to 50 ° C and after stirring for 1 hour, the reaction mixture was poured into 300 mL of 1M hydrochloric acid. 150 ml of water was added and the mixture was stirred at room temperature. The precipitated crystals were aspirated and dried at 90 ° C. 30 g of 3-chloro-3'-hydroxypropioanilide VI (75% of theory), m.p.
Príklad 2Example 2
Príprava 7-hydroxy-3,4-dihydrokarbostyriluPreparation of 7-hydroxy-3,4-dihydrocarbostyril
3-Chlór-3'-hydroxypropioanilid VI (0,15 mol), chlorid hlinitý (1,15 mol), chlorid sodný (0,3 mol) a chlorid draselný (0,26 mol) boli zmiešané a zahrievané na olejovom kúpeli pri teplote 155 až 160 °C počas jednej hodiny. Potom bola zmes odstavená z kúpeľa a do zmesi bolo za miešania naliatych 750 g zmesi vody s ľadovou triešťou. Vymiešaním sa vylúčila pevná látka, ktorá bola odsatá a premytá vodou. Po usušení bolo získaných 87 % surového produktu 7-hydroxy-3,4-dihydrokarbostyrilu IV. Surový produkt bol kryštalizovaný zo 120 ml 50 % vodného etanolu s prídavkom aktívneho uhlia. Po filtrácii a ochladení bol vylúčený produkt odsatý a usušený. Bolo získaných 70 % teoretického výťažku 7-hydroxy-3,4-dihydrokarbostyrilu IV s teplotou topenia 237 - 238 °C. Podľa HPLC analýzy tento produkt obsahoval 2 % nečistoty, ktorá bola identifikovaná pomocou LC-MS ako látka s molekulovou hmotnosťou nižšou o 2 jednotky než produkt, to znamená že nečistotou je 7-hydroxykarbostyril 1. Štruktúra bola tiež potvrdená z NMR spektier vzorky, ktorá obsahovala väčšie množstvo tejto nečistoty (6%).3-Chloro-3'-hydroxypropioanilide VI (0.15 mol), aluminum chloride (1.15 mol), sodium chloride (0.3 mol) and potassium chloride (0.26 mol) were mixed and heated in an oil bath at 155-160 ° C for one hour. The mixture was removed from the bath and 750 g of ice-water mixture were poured into the mixture with stirring. Stirring resulted in a solid which was aspirated and washed with water. After drying, 87% of the crude 7-hydroxy-3,4-dihydrocarbostyril IV product was obtained. The crude product was crystallized from 120 ml of 50% aqueous ethanol with the addition of activated carbon. After filtration and cooling, the precipitated product was filtered off with suction and dried. 70% of the theoretical yield of 7-hydroxy-3,4-dihydrocarbostyril IV with a melting point of 237-238 ° C was obtained. According to HPLC analysis, this product contained 2% impurity, which was identified by LC-MS as having a molecular weight lower than 2 units than the product, i.e. the impurity is 7-hydroxycarbostyril 1. The structure was also confirmed from the NMR spectra of the sample containing more of this impurity (6%).
Príklad 3Example 3
Čistenie 7-hydroxy-3,4-dihydrokarbostyriluPurification of 7-hydroxy-3,4-dihydrocarbostyril
2550 g 7-hydroxy-3,4-dihydrokarbostyrilu s obsahom nečistoty 1 (6 % podľa HPLC) bolo rozpustených v 35 1 metanolu. K roztoku bolo pridaných 100 g katalyzátora, ktorý obsahoval 2,35 % Pd (v sušine) na C a 45 % vody. Následná hydrogenácia bola uskutočnená vodíkom za tlaku 3,5 MPa pri teplote 75 - 80 °C v autokláve za miešania počas 7 hodín. Potom bola reakčná zmes samovoľne ochladená, katalyzátor bol odfiltrovaný, filtrát bol zahustený za zníženého tlaku na objem 8 litrov. Po ochladení na -18 °C bol získaný prvý podiel 1978 g (77,5 % teória) s čistotou podľa HPLC analýzy 99,9 %, obsah nečistoty 1 bol 0,04 %.2550 g of 7-hydroxy-3,4-dihydrocarbostyril containing impurity 1 (6% by HPLC) was dissolved in 35 l of methanol. To the solution was added 100 g of catalyst which contained 2.35% Pd (on dry basis) on C and 45% water. Subsequent hydrogenation was performed with hydrogen at 3.5 MPa at 75-80 ° C in an autoclave with stirring for 7 hours. After the reaction mixture was spontaneously cooled, the catalyst was filtered off, and the filtrate was concentrated under reduced pressure to a volume of 8 liters. After cooling to -18 ° C, a first crop of 1978 g (77.5% of theory) was obtained with a purity of 99.9% according to HPLC analysis, an impurity 1 content of 0.04%.
................
Filtrát bol potom zahustený na 1 liter a po ochladení na -18 °C bol získaný druhý podiel 307 g (12 % teória) s čistotou podľa HPLC analýzy 99,1 %, obsah nečistoty 1 bol 0,06 %.The filtrate was then concentrated to 1 liter and, after cooling to -18 ° C, a second crop of 307 g (12% of theory) was obtained with HPLC purity of 99.1%, impurity 1 content of 0.06%.
Spojením oboch podielov bolo získaných 2285 g (89,5 % teória) 7-hydroxy-3,4-dihydrokarbostyrilu s čistotou 99,8 % a obsahom nečistoty 1 0,04 %.Combining both parts yielded 2285 g (89.5% of theory) of 7-hydroxy-3,4-dihydrocarbostyril with a purity of 99.8% and an impurity content of 1.04%.
Claims (6)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZ20050338A CZ300351B6 (en) | 2005-05-26 | 2005-05-26 | Process for preparing 7-hydroxy-3,4-dihydrocarbostyril |
Publications (2)
Publication Number | Publication Date |
---|---|
SK50372006A3 true SK50372006A3 (en) | 2006-12-07 |
SK287896B6 SK287896B6 (en) | 2012-03-02 |
Family
ID=37482386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK5037-2006A SK287896B6 (en) | 2005-05-26 | 2006-04-07 | Process for preparing 7-hydroxy-3,4-dihydrocarbostyril |
Country Status (2)
Country | Link |
---|---|
CZ (1) | CZ300351B6 (en) |
SK (1) | SK287896B6 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104356063A (en) * | 2014-10-16 | 2015-02-18 | 华东师范大学 | Preparation method of 7-hydroxy-3,4-dihydro-2-(1H) carbostyril |
CN109776408B (en) * | 2017-11-14 | 2022-12-20 | 上海医药工业研究院 | Preparation method of 7-hydroxy-2-quinolinone |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS48103590A (en) * | 1972-04-13 | 1973-12-25 | ||
US5006528A (en) * | 1988-10-31 | 1991-04-09 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
JPH07247271A (en) * | 1994-01-21 | 1995-09-26 | Otsuka Pharmaceut Co Ltd | 3,4-dihydrocarbostyril derivative |
JP4232211B2 (en) * | 1998-03-19 | 2009-03-04 | エア・ウォーター株式会社 | Method for producing 3,4-dihydrocarbostyrils |
-
2005
- 2005-05-26 CZ CZ20050338A patent/CZ300351B6/en not_active IP Right Cessation
-
2006
- 2006-04-07 SK SK5037-2006A patent/SK287896B6/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CZ300351B6 (en) | 2009-04-29 |
CZ2005338A3 (en) | 2007-01-17 |
SK287896B6 (en) | 2012-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104844585B (en) | Method for preparing brexpiprazole | |
US7902377B2 (en) | Method for preparing medetomidine and its salts | |
EP1480953B1 (en) | Process for preparing aripiprazole | |
CN110240586A (en) | The preparation method of 2,3- dihydro -1H- benzo [f] chroman -2- amine derivative | |
EP1873151B1 (en) | Improved process for producing moxonidine | |
JP4478140B2 (en) | Preparation of carbostyril compounds for pharmaceutical use | |
AU2012264476B2 (en) | Process for the preparation of paliperidone | |
WO2007118923A1 (en) | A process for the preparation of aripiprazole and intermediates thereof | |
SK50372006A3 (en) | Process for preparing 7-hydroxy-3,4-dihydrocarbostyril | |
WO2015111085A2 (en) | Processes for the preparation of eltrombopag and pharmaceutically acceptable salts, solvates and intermediates thereof | |
CA3146869A1 (en) | Process for the preparation of a nitric oxide donating prostaglandin analogue | |
WO2023082839A1 (en) | Filgotinib preparation method | |
CN101137646A (en) | Synthesis of ccr5 antagonists | |
CN107382753B (en) | A kind of preparation method of high-purity hydrochloric acid ritodrine | |
US20100130744A1 (en) | Process for the preparation of aripiprazole | |
JP5065020B2 (en) | Process for producing levofloxacin or a hydrate thereof | |
CN106243050B (en) | A kind of method of suitable industrialized production Clobazam | |
WO2013020672A1 (en) | Process for the preparation of aripiprazole | |
JPH07247271A (en) | 3,4-dihydrocarbostyril derivative | |
CN108069900B (en) | Preparation method and application of aripiprazole hydrochloride | |
CN111100042A (en) | Preparation method of 2-methoxy-5-sulfonamide benzoic acid | |
JP6023770B2 (en) | Method for producing anhydrous aripiprazole crystals B | |
CN108503580A (en) | A kind of preparation method of Eliquis intermediate | |
CN111978264B (en) | Industrial production method of deferasirox | |
JP2001002621A (en) | Purification of polyprenyl-based compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TC4A | Change of owner's name |
Owner name: ZENTIVA, K.S., PRAHA, DOLNI MECHOLUPY, CZ Effective date: 20120524 |
|
MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20190407 |